NewAmsterdam Pharma Company N.V. (NAMS) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-12-02
4:30 pm
Purchase
2022-11-2213GNEWAMSTERDAM PHARMA CO NV SHS
NAMS
RA CAPITAL MANAGEMENT L.P.4,333,333
5.290%
4,333,333increase
(New Position)
Filing
History
2022-12-02
4:24 pm
Purchase
2022-11-2213DNEWAMSTERDAM PHARMA CO NV SHS
NAMS
BCLS II Investco, LP4,000,000
4.900%
4,000,000increase
(New Position)
Filing
History
2022-12-02
4:05 pm
Purchase
2022-11-2213GFRAZIER LIFESCIENCES ACQ CORP
FLAC
Morningside Venture Investments Ltd5,065,846
6.210%
5,065,846increase
(New Position)
Filing
History
2022-12-02
06:01 am
Purchase
2022-11-2213GNEWAMSTERDAM PHARMA CO NV SHS
NAMS
AMGEN INC
AMGN
4,910,000
6.000%
4,910,000increase
(New Position)
Filing
History
2022-12-01
5:33 pm
Purchase
2022-11-2213DNEWAMSTERDAM PHARMA CO NV SHS
NAMS
Frazier Lifesciences Sponsor LLC9,801,333
12.000%
9,801,333increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2